Pharmacotherapy in pulmonary infection among COPD patients
Identification of organism behind pulmonary infection and prescription pattern for management of COPD.
Versandkostenfrei!
Versandfertig in 6-10 Tagen
39,99 €
inkl. MwSt.
PAYBACK Punkte
20 °P sammeln!
The purpose of this study was to identify the causative agent and antimicrobial drugs in pulmonary infection among acute exacerbation of COPD patients. The study also observed the effectiveness of bronchodilators (via peak expiratory flow meter) in combination used for management of AECOPD patients admitted in the hospital. The study settled on the most effective antimicrobial and most appropriate drug combination of bronchodilator for its management. COPD is the 3rd leading disease worldwide causing chronic morbidity and mortality and also the leading disease for hospital admission. Yet, COPD...
The purpose of this study was to identify the causative agent and antimicrobial drugs in pulmonary infection among acute exacerbation of COPD patients. The study also observed the effectiveness of bronchodilators (via peak expiratory flow meter) in combination used for management of AECOPD patients admitted in the hospital. The study settled on the most effective antimicrobial and most appropriate drug combination of bronchodilator for its management. COPD is the 3rd leading disease worldwide causing chronic morbidity and mortality and also the leading disease for hospital admission. Yet, COPD remain under diagnosed and untreated. One reason for this may be that many physician still believe that there are no effective treatment for COPD, and for which the patient is wholly blamed since one of the foremost cause of this is cigarette smoking, along with other pollutant which the patient get exposed in outdoor conditions and indoor conditions.
Andere Kunden interessierten sich für
